The Autism Spectrum Disorders / Vaccine Link Debate: a Health Social Movement

Total Page:16

File Type:pdf, Size:1020Kb

The Autism Spectrum Disorders / Vaccine Link Debate: a Health Social Movement THE AUTISM SPECTRUM DISORDERS / VACCINE LINK DEBATE: A HEALTH SOCIAL MOVEMENT by Margaret Anna Kerr B.A. Hollins University 2002 M.A. University of Pittsburgh 2004 Submitted to the Graduate Faculty of the College of Arts and Science in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2009 UNIVERSITY OF PITTSBURGH School of Arts and Sciences This dissertation was presented by Margaret Anna Kerr It was defended on May 6th, 2009 and approved by Dr. Phyllis Coontz, Associate Professor of Sociology, University of Pittsburgh Dr. John Markoff, University Professor of Sociology, University of Pittsburgh Dr. Keri Rodriguez, Assistant Professor of Sociology, University of Pittsburgh Dr. Matthew Schneirov, Associate Professor of Sociology, Duquesne University Dr. John Marx Professor of Sociology, University of Pittsburgh ii Copyright © by Margaret Anna Kerr, PhD 2009 iii Autism and Vaccines: A Health Social Movement Margaret Anna Kerr, Ph.D. University of Pittsburgh, 2009 ABSTRACT Over the past ten years, the parents and loved ones of thousands of individuals afflicted with Autism Spectrum Disorders (ASD) have mobilized around the idea that vaccines play a causative role in ASDs. The US Federal government and Western mainstream medicine refute this, claiming evidence refutes any causal link between vaccines and ASD. The result has been a heated dispute between ASD/vaccine link (ASD/VL) activists and mainstream medicine, both claiming legitimacy based on their own scientific research. To examine this controversy and why ASD/VL activists continue to mobilize around a scientific hypothesis that has been largely disproved, I surveyed and conducted in-depth interviews with ASD/VL activists and examined artifacts from the movement. Utilizing the theoretical framework on Health Social Movements (HSM) developed by Phil Brown and theories on boundary work developed by Thomas Gieryn I examined how and why ASD/VL activists, in collaboration with politicians and scientists, organized a movement to prove there is significant evidence showing a causative link between vaccines and ASDs. I explored how mobilization occurred around several key events including the US Congressional hearings on vaccine safety, the Immunization Safety Review Committee hearings, reports published by the Institute of Medicine, and the release of the Simpsonwood Retreat transcript. I found that while ASD/VL activists became lay experts and used scientific evidence to build their iv argument, they depended on their own experiential knowledge to inform their personal beliefs on ASD causation and treatment. My findings have significant impact for the study of health social movements and the study of contested illnesses. v TABLE OF CONTENTS ABSTRACT ................................................................................................................................. IV PREFACE .................................................................................................................................. XII 1.0 INTRODUCTION ........................................................................................................ 1 1.1 THEORETICAL FOUNDATIONS ................................................................... 4 1.1.1 The Production of Cultural Authority ........................................................ 4 1.1.2 Boundary Work ............................................................................................ 7 1.1.3 Health Social Movements ........................................................................... 11 1.2 METHODOLOGY ............................................................................................ 19 1.2.1 Internet as a Site of Movement Mobilization and Action ....................... 20 1.2.2 Dataset 1: Survey Data ............................................................................... 22 1.2.2.1 Gaining Access .................................................................................... 23 1.2.2.2 The Survey ........................................................................................... 24 1.2.3 Data Set 2: In-depth Interviews ................................................................. 25 1.2.4 Data Set 3: Artifacts .................................................................................... 26 1.2.5 Analysis ........................................................................................................ 27 1.2.5.1 Reliability ............................................................................................. 30 2.0 THE MOVEMENT BEGINS .................................................................................... 32 2.1 AUTISM AND VACCINES: MAKING THE CONNECTION .................... 36 2.2 THE MAKINGS OF A MOVEMENT ............................................................ 40 2.2.1 Demographic Data ...................................................................................... 41 vi 2.2.1.1 Survey .................................................................................................. 41 2.2.1.2 In-depth Interviews ............................................................................ 45 2.3 MOVEMENT GROUP PROFILES: EARLY BIRDS ................................... 46 2.3.1 National Vaccine Information Center and Barbara Lo Fisher .............. 48 2.3.2 Defeat Autism Now ..................................................................................... 51 2.3.3 National Autism Association ...................................................................... 52 2.3.4 Unlocking Autism........................................................................................ 55 2.3.5 SafeMinds .................................................................................................... 57 3.0 MOVING TO THE FRONT LINES ........................................................................ 63 3.1 BURTON’S HEARINGS ON VACCINE SAFTEY ....................................... 63 3.2 THE INSTITUTE OF MEDICINE .................................................................. 66 3.3 SIMPSONWOOD .............................................................................................. 69 3.3.1 Presenting the Case ..................................................................................... 71 3.3.2 Where Do We Go From Here? .................................................................. 75 3.3.3 Robert F. Kennedy, Jr. ............................................................................... 83 4.0 CONTESTS IN SCIENCE ........................................................................................ 88 4.1 GAINING ACCESS ........................................................................................... 88 4.2 DATA WARS ..................................................................................................... 96 4.3 THE SCIENTIFIC SHOWDOWN AT THE IOM ....................................... 101 5.0 RESURGENCE OF MOBILIZATION ................................................................. 110 5.1 THE NEXT GENERATION .......................................................................... 110 5.1.1 Generation Rescue and Jenny McCarthy ............................................... 110 5.1.2 NoMercury.org .......................................................................................... 119 vii 5.1.3 Advocates for Children's Health Affected by Mercury Poisoning and Autism Action Collation .......................................................................................... 121 5.1.4 Moms Against Mercury ............................................................................ 123 5.2 DAMAGE CONTROL .................................................................................... 130 5.2.1 Boundary work: Expulsion from the Ranks .......................................... 131 5.2.2 Framing tactics .......................................................................................... 136 5.2.3 Movement/Countermovement Dynamics ............................................... 138 6.0 IN THEIR OWN WORDS ...................................................................................... 141 6.1 DON’T CALL ME ANTI-SCIENCE ............................................................. 142 6.2 TRUST IN INSTITUTIONS ........................................................................... 143 6.3 DETERMINING CREDIBILITY .................................................................. 151 6.4 ACTIVISM WITHOUT ACTIVISTS ........................................................... 157 6.4.1 Don’t call me an activist ........................................................................... 157 6.4.2 Getting the Word Out ............................................................................... 163 7.0 THE ROLE AND INFLUENCE OF MEDICAL PROVIDERS ......................... 167 7.1 GOODBYE TO THE GOLDEN AGE ........................................................... 168 7.2 ATTITUDES TOWARDS MEDICAL PROVIDERS .................................. 169 8.0 THE MAKING OF POLITICIZED COLLECTIVE ILLNESS IDENTITY .... 179 8.1 SHARED IDENTITY: YOU FEEL THE SAME WAY? ............................ 179 8.1.1 Stress on Relationships ............................................................................. 180 8.1.2 Self Blame .................................................................................................. 185 8.2 COMING TOGETHER IN POLITICAL ACTION .................................... 187 9.0 HEALTH
Recommended publications
  • To Vaccinate Or Not to Vaccinate: a Qualitative Description of the Information Available on Popular Search Engines Regarding the Vaccine Debate
    Butler University Digital Commons @ Butler University Undergraduate Honors Thesis Collection Undergraduate Scholarship 2016 To Vaccinate or Not To Vaccinate: A Qualitative Description of the Information Available on Popular Search Engines Regarding the Vaccine Debate. Madeline Rhinesmith Butler University, [email protected] Follow this and additional works at: https://digitalcommons.butler.edu/ugtheses Part of the Communication Technology and New Media Commons, and the Health Communication Commons Recommended Citation Rhinesmith, Madeline, "To Vaccinate or Not To Vaccinate: A Qualitative Description of the Information Available on Popular Search Engines Regarding the Vaccine Debate." (2016). Undergraduate Honors Thesis Collection. 343. https://digitalcommons.butler.edu/ugtheses/343 This Thesis is brought to you for free and open access by the Undergraduate Scholarship at Digital Commons @ Butler University. It has been accepted for inclusion in Undergraduate Honors Thesis Collection by an authorized administrator of Digital Commons @ Butler University. For more information, please contact [email protected]. To Vaccinate or Not To Vaccinate: A Qualitative Description of the Information Available on Popular Search Engines Regarding the Vaccine Debate. A Thesis Presented to the Department of Science, Technology and Society College of Liberal Arts in Sciences and The Honors Program of Butler University In Partial Fulfillment of the Requirements for Graduation Honors Madeline Louise Rhinesmith April 25, 2016 TABLE OF CONTENTS ABSTRACT 1 INTRODUCTION 2 LITERATURE REVIEW 6 METHODS 12 TABLE 1 15 RESULTS 21 TABLE 2 22 DISCUSSION 23 TABLE 3 24 CONCLUSION 30 REFERENCE LIST 32 Abstract The current study looks at the assumption that that more information, along with improved access to that information could lead to more informed decisions through evaluating and critically reflecting on the vaccine debate.
    [Show full text]
  • Autism 2002 Mercury, Heavy Metals
    Autism 2002 Mercury, Heavy Metals... Toxicity Stephanie Cave, M.D., F.A.A.F.P. Dr. Cave received her M.D. from LSU Medical School in New Orleans, Louisiana in 1983. She completed a residency in 1986 and is board certified in Family Practice. She and her colleague, Dr. Amy Holmes, are presently treating over 1000 children with Autism Spectrum Disorder in a private clinic in Baton Rouge, Louisiana. Dr. Cave lectures on Autism and Vaccines and has recently published a book titled What Your Doctor May Not Tell You About Children's Vaccinations. Last summer she testified before the United States Congressional Committee on Governmental Reform regarding the mercury content in vaccines. AUTISM AND IMMUNIZATIONS Stephanie F. Cave, M.S., M.D., F.A.A.F.P. I am honored that you have asked me to speak at the Autism 2002 conference. I would like to talk to you about a subject close to my heart---autism spectrum disorder and the possible link to vaccines. Presently my colleague and I are treating over 1500 children with this problem. In the past five years we have seen an incredible number of children recover from this devastating illness and take their places beside their schoolmates and siblings. This subject, as you might expect, is a very controversial one, but I think you will agree with me before the end of this lecture that this is an epidemic in medicine unlike anything that we have seen in the past. The debate about vaccinations has been going on since the smallpox vaccine was given during the early part of the twentieth century.
    [Show full text]
  • Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children
    ORIGINAL CONTRIBUTION Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children ˚ ´ Pal Suren, MD, MPH Importance Prenatal folic acid supplements reduce the risk of neural tube defects Christine Roth, MSc in children, but it has not been determined whether they protect against other neu- Michaeline Bresnahan, PhD rodevelopmental disorders. Margaretha Haugen, PhD Objective To examine the association between maternal use of prenatal folic acid supplements and subsequent risk of autism spectrum disorders (ASDs) (autistic disor- Mady Hornig, MD der, Asperger syndrome, pervasive developmental disorder–not otherwise specified Deborah Hirtz, MD [PDD-NOS]) in children. Kari Kveim Lie, MD Design, Setting, and Patients The study sample of 85 176 children was derived from the population-based, prospective Norwegian Mother and Child Cohort Study W. Ian Lipkin, MD (MoBa). The children were born in 2002-2008; by the end of follow-up on March 31, Per Magnus, MD, PhD 2012, the age range was 3.3 through 10.2 years (mean, 6.4 years). The exposure of Ted Reichborn-Kjennerud, MD, PhD primary interest was use of folic acid from 4 weeks before to 8 weeks after the start of pregnancy, defined as the first day of the last menstrual period before conception. Synnve Schjølberg, MSc Relative risks of ASDs were estimated by odds ratios (ORs) with 95% CIs in a logistic George Davey Smith, MD, DSc regression analysis. Analyses were adjusted for maternal education level, year of birth, and parity. Anne-Siri Øyen, PhD Main Outcome Measure Specialist-confirmed diagnosis of ASDs. Ezra Susser, MD, DrPH Results At the end of follow-up, 270 children in the study sample had been diag- Camilla Stoltenberg, MD, PhD nosed with ASDs: 114 with autistic disorder, 56 with Asperger syndrome, and 100 with PDD-NOS.
    [Show full text]
  • 03-584V • FRED KING and MYLINDA KING, Parents of Jordan King, a Minor V. SECRETARY OF
    In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 03-584V (Filed: September 22, 2011) TO BE PUBLISHED1 * * * * * * * * * * * * * * * * * * * * * * * * * * * * FRED KING and MYLINDA KING, * parents of Jordan King, a minor, * Vaccine Act Interim Costs; * Fees for Omnibus Proceedings; Petitioners, * Expert Costs; Expenditures * For Original Research v. * Articles; Dr. Mark Geier. * SECRETARY OF HEALTH AND * HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * DECISION ON REMAND CONCERNING INTERIM COSTS HASTINGS, Special Master. In this case under the National Vaccine Injury Compensation Program (hereinafter “the Program”), the petitioners seek, pursuant to 42 U.S.C. § 300aa-15(e),2 an interim award for attorneys’ costs incurred in the course of the petitioners’ attempt to obtain Program compensation. On December 13, 2010, I issued a Decision Awarding Interim Costs, which was the fifth award of interim fees and/or costs issued in this case. The petitioners sought review of that Decision, and on 1 Because I have designated this document to be published, each party has 14 days within which to request redaction “of any information furnished by that party (1) that is trade secret or commercial or financial information and is privileged or confidential, or (2) that are medical files and similar files the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b); 42 U.S.C. § 300aa-12(d)(4)(B). Otherwise, this entire document will be available to the public. 2 The applicable statutory provisions defining the Program are found at 42 U.S.C. § 300aa- 10 et seq. (2006). Hereinafter, for ease of citation, all “§” references will be to 42 U.S.C.
    [Show full text]
  • (No Jab, No Pay) Bill 2015 Submission
    16 October, 2015 The Committee Secretary Senate Standing Committees on Community Affairs PO Box 6100 Parliament House CANBERRA ACT 2600 Dear Committee Secretary, Re: Submission to the Senate Community Affairs Legislation Committee Inquiry into the Social Services Legislation Amendment (No Jab, No Pay) Bill 2015 I am a Solicitor who has practiced in areas of law that have pertained to the issue of vaccination. Consequently, having conversed with professionals in various scientific and medical fields of practice on this issue and prepared matters for hearing based on their expertise, I make the following submission to emphasize the extent that the proposed legislation breaches fundamental human rights and the government’s responsibilities to it’s families and children. According to the Social Services Legislation Amendment (No jab, No pay) Bill 2015 Explanatory Memorandum and Statement of Compatibility with Human Rights: “This Bill will introduce a 2015 Budget measure relevant to families. This Bill amends the immunisation requirements for child care benefit, child care rebate and the family tax benefit Part A supplement. The changes will tighten the existing immunisation requirements for these payments, reinforcing the importance of immunisation and protecting public health, especially for children. From 1 January 2016, this measure makes these payments conditional on meeting the childhood immunisation requirements for children at all ages. Exemptions will only apply for valid medical reasons, or if the Secretary has determined in writing that a child meets the immunisation requirements. The Secretary will be able to determine that a child meets the immunisation requirements after considering any decision-making principles set out in a legislative instrument made by the Minister.
    [Show full text]
  • The National Vaccine Injury Compensation Program: Awareness, Perception, and Communication Considerations
    The National Vaccine Injury Compensation Program: Awareness, Perception, and Communication Considerations Developing a Comprehensive National Vaccine Injury Compensation Program Research Report Presented by Banyan Communications and Altarum Institute For the U.S. Health Resources and Services Administration Division of Vaccine Injury Compensation June 2010 Table of Contents 1. Introduction and Background ................................................................................................................. 1 a. VICP BACKGROUND: RELATED LEGISLATION ................................................................................................. 2 2. Review of the VICP Literature ................................................................................................................. 4 a. METHODOLOGY ............................................................................................................................................. 4 b. VICP PERCEPTION AND REACTION ................................................................................................................ 4 c. VICP MESSAGING AND PROMOTION ............................................................................................................. 7 3. Scan of the Field: VICP Players, Media, and the Online Environment .................................................... 12 a. METHODOLOGY ............................................................................................................................................. 12 b. VICP AND
    [Show full text]
  • Lower Autism Risk with Folic Acid Supplements in Pregnancy 12 February 2013
    Lower autism risk with folic acid supplements in pregnancy 12 February 2013 Women who took folic acid supplements in early of folic acid supplements in the mother during pregnancy almost halved the risk of having a child pregnancy and a reduced risk of childhood autism. with autism. Beginning to take folic acid supplements later in pregnancy did not reduce the "The study does not prove that folic acid risk. This is shown in new findings from the ABC supplements can prevent childhood autism. Study and Norwegian Mother and Child Cohort However, the findings are so apparent that they Study published in the Journal of The American constitute a good argument to further examine Medical Association (JAMA). possible causal mechanisms. It should also be ascertained whether folic acid is associated with a Women who took folic acid supplements from four reduced risk of other brain disorders in children," weeks before conception to eight weeks into says Surén. pregnancy had a 40 per cent lower risk of giving birth to children with childhood autism (classic Emphasises the importance of folic acid autism). Use of folic acid supplements midway supplements through pregnancy (week 22) had no effect. The results support the Norwegian Directorate of The findings only apply to a lower risk of childhood Health's recommendations for folic acid autism, the most severe form of autism. The supplements during pregnancy and emphasise the results show no reduction in the risk of atypical or importance of starting early—preferably before unspecific autism. The study also investigated the conception. prevalence of Asperger syndrome, but the number of examined children was too low to give a reliable Method result.
    [Show full text]
  • Disability in an Age of Environmental Risk by Sarah Gibbons a Thesis
    Disablement, Diversity, Deviation: Disability in an Age of Environmental Risk by Sarah Gibbons A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Doctor of Philosophy in English Waterloo, Ontario, Canada, 2016 © Sarah Gibbons 2016 I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public. ii Abstract This dissertation brings disability studies and postcolonial studies into dialogue with discourse surrounding risk in the environmental humanities. The central question that it investigates is how critics can reframe and reinterpret existing threat registers to accept and celebrate disability and embodied difference without passively accepting the social policies that produce disabling conditions. It examines the literary and rhetorical strategies of contemporary cultural works that one, promote a disability politics that aims for greater recognition of how our environmental surroundings affect human health and ability, but also two, put forward a disability politics that objects to devaluing disabled bodies by stigmatizing them as unnatural. Some of the major works under discussion in this dissertation include Marie Clements’s Burning Vision (2003), Indra Sinha’s Animal’s People (2007), Gerardine Wurzburg’s Wretches & Jabberers (2010) and Corinne Duyvis’s On the Edge of Gone (2016). The first section of this dissertation focuses on disability, illness, industry, and environmental health to consider how critics can discuss disability and environmental health in conjunction without returning to a medical model in which the term ‘disability’ often designates how closely bodies visibly conform or deviate from definitions of the normal body.
    [Show full text]
  • Interview of Dr. Boyd E. Haley by Teri Small
    B.E. Haley and T. Small/Medical Veritas 3 (2006) 921–934 921 Interview with Dr. Boyd E. Haley: Biomarkers supporting mercury toxicity as the major exacerbator of neurological illness, recent evidence via the urinary porphyrin tests Boyd E. Haleya, PhD and Teri Smallb aProfessor and Chair bAutismOne Radio Department of Chemistry 1816 Houston Ave. University of Kentucky Fullerton, CA 92833 USA Email: [email protected] Email: [email protected] Website: www.autismone.org Abstract In the recent past, several biological finds have supported the hypothesis that early exposure of infants to Thimerosal was the major exacerbation factor in the increase in autism-related disorders since the advent of the mandated vaccine program. These initially included the observations of a genetic susceptibility impairing the excretion of mercury and the increased retention of mercury by autistic children. This was followed by data indi- cating that autistics have low levels of the natural compound glutathione that is necessary for the bilary excretion of mercury, possibly explaining the genetic susceptibility. Other observations clearly point out that various biochemical processes are inhibited at exceptionally low nanomolar levels of Thimerosal, including the killing of neurons in culture, the inhibition of the enzyme that makes methyl-B12, the inhibition of phagocytosis (the first step in the innate and acquired immune system), the inhibition of nerve growth factor function at levels not cytotoxic, and the negative effect on brain dendritic cells. It is also now quite clear from primate studies that Thimerosal, or more correctly, the ethylmercury from Thimerosal delivers mercury to the brain, and causes brain inorganic mercury levels higher than equal levels of methylmercury.
    [Show full text]
  • Vaxxed Testimony of Hpv Vaccine Damaged Patients
    Vaxxed Testimony Of Hpv Vaccine Damaged Patients Skiable and plushy Poul concluded her volvas mismates while Carlin bull some humanity inanimately. Is Tristan mangiest or ton-up when homogenize some shake-up house deuced? Happening Mohamad beckon some grabbers after retuse Glynn dollops spicily. He walked right to improved strength and because no evidence of outreach page, hpv vaccine is a burden on the vaccine uptake and reveal the There please never eliminate a vaccine that has worked for Corona Viruses. The act acknowledged that vaccine injuries and deaths are real faith that the vaccine injured and their families should be financially supported and that vaccine safety protections were needed in the mass vaccination system. Here met the later to the FEDERAL TRADE COMMISSION task force MERCK to stop airing the manipulative commercial. Some of plan are neither for causing autoimmune. And broadcast day half that, journey felt a little heat better he made a beautiful bit more progress. With them correct training stimulus, one taking these patients could retrain their brains to somewhat different regions for vision dental were not damaged by her stroke. Which scientists does business actually he too. Herd immunity is most a sample size percentage of a downtown area. Most generous who get vaccines have no serious problems. Vaxxed bus tour of the US? It infuriates the opposition, which then reacts to pursue advantage. My parents vaccinated us after that. Who decides if comments are shrewd or on? And across, you can watch should they always begin conspiring frantically about how we hide the mistake! Like any parent who thinks they mention doing the right word he was vaxxed on CDC schedule.
    [Show full text]
  • Monthly Meeting President Armando Sandoval Vice President Our Next Monthly Meeting Will Be Tuesday, February 10,2015 Rebekah Sandoval at 6:30 P.M
    The only nationally affiliated group in El Paso. February 2015 OFFICERS Bonnie Perez Monthly Meeting President Armando Sandoval Vice President Our next monthly meeting will be Tuesday, February 10,2015 Rebekah Sandoval at 6:30 p.m. at Region 19 Education Service Center, 6611 Boeing. Secretary Monique Armendariz Join us to discuss issues important to families and to network with Treasurer Karla Ronquillo others who understand. Childcare and refreshments will be available. Executive Administrative If you would like to see some of our books, please call the Assistant BOARD office to schedule an appointment. Messages are checked daily. Feel Adriana Araiza free to call us for any information at 772-9100 or send us an email to Michelle Lopez Ainée Robles [email protected] Joe Villalobos HONORARY BOARD Join us on Facebook! NATIONAL www.facebook.com/autismsocietyep AUTISM SOCIETY Sandra Smith Advanced Placement Specialist INDEX General Information 1 MONTHLY Upcoming Events 2 MEETINGS General What’s Going On 3 Membership A Letter from the President 4 Meetings are held the Submit Your Family’s Stories 5 second Tuesday of every month at Re- gion 19 ESC at 6611 Boeing beginning at 6:30 p.m. Board Meetings are held on the last Monday of every month at 6:30 p.m. All members are welcome to attend, and your input is always 1 AUTISM SOCIETY OF EL PASO AUTISM SOCIETY OF EL PASO UPCOMING EVENTS 2014: February 10, 2015 Monthly Support Group Meeting 6:30 p.m. Region 19 Education Service Center 6611 Boeing Dr. February 23, 2015 Monthly Board Meeting 6:30 p.m.
    [Show full text]
  • IN the UNITED STATES COURT of FEDERAL CLAIMS OFFICE of SPECIAL MASTERS No. 01-162V Filed: February 12, 2009 to Be Published
    IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS No. 01-162V Filed: February 12, 2009 To Be Published * * * * * * * * * * * * * * * * * * * * * * * * * * * * COLTEN SNYDER, by and through * KATHRYN SNYDER and JOSEPH SNYDER, * his natural guardians and next friends * Omnibus Autism * Proceeding; * Autism Spectrum Disorder, * Pervasive Developmental * Disorder, Causation, Petitioners, * Measles, MMR, Mercury, * Thimerosal, Waiver v. * Applying Daubert, * Weight of Expert Opinions, SECRETARY OF THE DEPARTMENT * Credibility of Witnesses OF HEALTH AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * Christopher W. Wickersham, Sr., Esq., Lloyd Bowers, Esq., and Thomas B. Powers, Esq., for petitioners. Alexis S. Babcock, Esq., Katherine Esposito, Esq., Voris Johnson, Esq., and Vincent Matanoski, Esq., U.S. Department of Justice, Washington, DC, for respondent. DECISION1 Vowell, Special Master: On March 22, 2001, Kathryn and Joseph Snyder [“petitioners”] filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. 1 Vaccine Rule 18(b) provides the parties 14 days to request redaction of any material “(i) which is trade secret or commercial or financial information which is privileged and confidential, or (ii) which are medical files and similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” 42 U.S.C. § 300aa12(d)(4)(B). Petitioners have waived their right to request such redaction. See Petitioners’ Notice to W aive the 14-Day “W aiting” Period as Defined in Vaccine Rule 18(b), filed December 2, 2008. Respondent also waived the right to object to the disclosure of information submitted by respondent. See Respondent’s Consent to Disclosure, filed January 14, 2009. Accordingly, this decision will be publicly available immediately after it is filed.
    [Show full text]